
Jointly Provieded by: Penn Medicine and ViralEd, Inc.
About the Program
Program Overview
The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is live webcast every Thursday at 12:00pm Eastern Time starting in October through June. All webcasts will be available for on-demand viewing immediately following the live broadcast. CME credit will be available for 24 hours following the start of each webcast.
Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.
Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hivgrandrounds for easy access.
Target Audience
This program has been designed for Family
Medicine, Psychiatry, Public Health and General Preventive Medicine, Internal Medicine, Internal Medicine - Infectious Diseases, All Specialties.
Commercial Support Acknowledgement
HIV Grand Rounds is supported by independent educational grants from ViiV Healthcare, Merck & Co. and Gilead Sciences, Inc.
Learning Objectives
After completing this activity, participants should be better able to:
- Describe how to apply in clinical practice approaches for preventing HIV infection and getting newly diagnosed patients rapidly into care
- Describe how to manage various patient populations, such as the aging
patient with HIV infection, including issues associated with
cardiovascular and bone disease, PWIDs and underserved populations
- Discuss the basic science concepts involved with HIV and be able to
apply those concepts to HIV therapeutics, epidemiology, and other issues involved in
HIV patient care and HIV prevention
- Discuss how to individualize ARV therapy for the treatment-naïve and treatment-experienced patients to support adherence and patient satisfaction
Current Session Learning Objectives
After completing this activity, participants should be better able to:
- Discuss complex, multidimensional biopsychosocial phenotypes in HIV and their clinical implications.
- Evaluate how baseline comorbidities and clinical factors shape the progression of biopsychosocial phenotypes in HIV-infected individuals.
- Analyze biomarker compartmentalization between cerebrospinal fluid and blood.
Course Directors
Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania
Katherine Bar, MD
Associate Professor
Department of Medicine
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania
Florence Momplaisir, MD, MSHP, FACP
Assistant Professor of Medicine
Vice Chair for Diversity, Equity and Inclusion (DEI) in Infectious Diseases
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
Next Session and Participation Information
Presented live at 12:00 PM ET, weekly on Thursdays and anytime On-Demand
- Delivered via webinar directly to you and/or your clinic
- You, or your clinic's coordinator, will receive a weekly email with topic, speaker and webinar link
- Sessions can be viewed in a large conference room or auditorium for large group viewing and participation, or directly on your personal computer, tablet or smart device
If CME credit is desired for any of the live sessions, proceed to https://upenn.cloud-cme.com to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit.
Live Session Topics and Speakers
January 30, 2025
HIV Prevention for Cisgender Women: Improving the PrEP Care Continuum
Jessica Ridgway, MD
Click HERE to View On-Demand
February 6, 2025
The Top Ten Publications in HIV Medicine in 2024
Ian Frank, MD
Click HERE to View On-Demand
February 13, 2025
Stigma & Syndemics: a challenge in HIV and viral hepatitis elimination research
M. Elle Saine, MD, PhD, MA
Click HERE to View On-Demand
February 20, 2025
Sex differences in excess weight gain among people initiating or switching to integrase strand transfer inhibitors (INSTIs) for HIV treatment
Florence Momplaisir, MD, MSHP, FACP
Click HERE to View On-Demand
February 27, 2025
Decoding the HIV Reservoir
Laura A. Vella, MD, PhD
Click HERE to View On-Demand
March 6, 2025
Current Approaches in the Development of New Drugs and Regimens for Tuberculosis
David L. Holtzman, MD
Click HERE to View On-Demand
March 20, 2025
Highlights from CROI 2025, Part I: ART and Comorbidities
Renslow Sherer, MD
Click HERE to View On-Demand
March 27, 2025
Using implementation science to enhance sexual wellness among people who receive care at safety-net clinics in the Southern U.S.
Jessica Sales, PhD, MA
Click HERE to View On-Demand
April 3, 2025
HIV Care Challenges For Pregnant and Breastfeeding Women in South Africa and a Discussion about Supporting Safe Feeding Options
Natasha Davies, MBChB, MPH, HIV Man Dip (SA)
Click HERE to View On-Demand
April 10, 2025
Highlights from CROI 2025, Part II: Epidemiology, Prevention and Coinfections
Renslow Sherer, MD
Click HERE to View On-Demand
April 24, 2025
Leveraging Implementation Science to Close Equity Gaps in PrEP Service Delivery
Latesha Elopre, MD, MSPH
Click HERE to View On-Demand
May 1, 2025
Protecting Neurobehavioral Outcomes in People with HIV
Ronald Joseph Ellis, MD, PhD
Click HERE to Register
TO VIEW PREVIOUS HIV GRAND ROUNDS PLEASE SEE BELOW:
|
Hardware/Software Notice
You will need Internet to participate in this activity.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Penn Medicine and ViralEd. Penn
Medicine is jointly accredited by the Accreditation Council for Continuing
Medical Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.
Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians
should claim only the credit commensurate with the extent of their
participation in the activity.
Nurses/Pharmacists:
This activity is not approved
for nursing or pharmacy contact hours
PAs: AAPA accepts certificates of participation for educational
activities certified for AMA PRA Category 1 Credit™ from organizations
accredited by ACCME or a recognized state medical society. PAs may receive a
maximum of 1.00 Category 1 credits for completing
this activity.
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at Penn Medicine Office of
Continuing Medical and Interprofessional Education for individuals who are in a
position to control the content of an educational activity to disclose to the
learners all relevant financial relationships that they have with any commercial
interest that provide products or services that may be relevant to the content
of this continuing education activity.
For this purpose, we consider relationships of the person involved to
include financial relationships of a spouse or partner.
The
intent of this policy is to ensure that Penn CME/CE certified activities
promote quality and safety, are effective in improving medical practice, are based
on valid content, and are independent of control from commercial interests and
free of commercial bias. Peer review of all content was conducted for all
faculty presentations whose disclosure information was found to contain
relationships that created a conflict of interest relevant to the topic of
their presentation. In addition, all faculty were instructed to provide
balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of Continuing Medical and Interprofessional Education (CME and
IPCE) have disclosed that they have no relevant financial
relationships with any commercial interests related to the content of
this
educational activity. Any peer reviewer with a potential conflict of
interest will recuse themselves from the peer review process.
The following faculty or planning committee members have
disclosed that they have no relevant financial relationships with any
commercial interests related to the content of this educational activity:
Florence Momplaisir, MD (Program Co-Director)
Ronald Joseph Ellis, MD, PhD (Presenter)
Planning Committee Members:
- ViralEd, Inc.: Brian Boyle, MD; Rick Gordon
|
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
Ian Frank, MD (Program Co-director)
- Membership on Advisory Committees or Review Panels, Board Membership, etc.: ViiV; Johnson & Johnson; Gilead (Relationship Ended)
- Consulting Fee (All Relationships Ended): Gilead; Merck; Moderna
- Grant or Research Support: Pfizer; Gilead; Johnson & Johnson (Relationship Ended); Sanofi Genzyme (Relationship Ended); Moderna (Relationship Ended)
Katherine Bar, MD (Program Co-director)
- Consulting Fee: AbbVie, ViiV (Relationship Ended)
|
Discussion of Investigational and/or Off-label Use of Commercial Products and Devices
The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside DA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
|